What Has Adjuvant Chemotherapy of Osteosarcoma Achieved? Discussion Paper

Overview

Journal J R Soc Med

Specialty General Medicine

Date 1983 Nov 1

PMID 6195337

Authors

R L Souhami

Affiliations

Soon will be listed here.

References

Jaffe N, Frei 3rd E, Watts H, Traggis D . High-dose methotrexate in osteogenic sarcoma: a 5-year experience. Cancer Treat Rep. 1978; 62(2):259-64. View

Ochs J, Freeman A, Douglass Jr H, Higby D, Mindell E, Sinks L . cis-Dichlorodiammineplatinum (II) in advanced osteogenic sarcoma. Cancer Treat Rep. 1978; 62(2):239-45. View

Rosen G, Marcove R, Caparros B, Nirenberg A, Kosloff C, Huvos A . Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery. Cancer. 1979; 43(6):2163-77. DOI: 10.1002/1097-0142(197906)43:6<2163::aid-cncr2820430602>3.0.co;2-s. View

ROSENBURG S, Chabner B, Young R, Seipp C, Levine A, Costa J . Treatment of osteogenic sarcoma. I. Effect of adjuvant high-dose methotrexate after amputation. Cancer Treat Rep. 1979; 63(5):739-51. View

Edmonson J, Green S, IVINS J, Gilchrist G, Cregan E, Pritchard D . Methotrexate as adjuvant treatment for primary osteosarcoma. N Engl J Med. 1980; 303(11):642-3. DOI: 10.1056/NEJM198009113031115. View

Ettinger L, Douglass Jr H, Higby D, Mindell E, Nime F, Ghoorah J . Adjuvant adriamycin and cis-diamminedichloroplatinum (cis-platinum) in primary osteosarcoma. Cancer. 1981; 47(2):248-54. DOI: 10.1002/1097-0142(19810115)47:2<248::aid-cncr2820470208>3.0.co;2-e. View

Rosen G, Caparros B, Huvos A, Kosloff C, Nirenberg A, Cacavio A . Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer. 1982; 49(6):1221-30. DOI: 10.1002/1097-0142(19820315)49:6<1221::aid-cncr2820490625>3.0.co;2-e. View

Bleyer W, Haas J, Feigl P, Greenlee T, SCHALLER Jr R, Morgan A . Improved three-year disease-free survival in osteogenic sarcoma. J Bone Joint Surg Br. 1982; 64(2):233-8. DOI: 10.1302/0301-620X.64B2.6978340. View

Rosen G, Nirenberg A . Chemotherapy for osteogenic sarcoma: an investigative method, not a recipe. Cancer Treat Rep. 1982; 66(9):1687-97. View

10.

Lange B, Levine A . Is it ethical not to conduct a prospectively controlled trial of adjuvant chemotherapy in osteosarcoma?. Cancer Treat Rep. 1982; 66(9):1699-704. View

11.

Sullivan M, SUTOW W, Taylor G . L-PHENYLALANINE MUSTARD AS A TREATMENT FOR METASTATIC OSTEOGENIC SARCOMA IN CHILDREN. J Pediatr. 1963; 63:227-37. DOI: 10.1016/s0022-3476(63)80333-9. View

12.

Djerassi I . Methotrexate infusions and intensive supportive care in the management of children with acute lymphocytic leukemia: follow-up report. Cancer Res. 1967; 27(12):2561-4. View

13.

Finklestein J, Hittle R, Hammond G . Evaluation of a high dose cyclophosphamide regimen in childhood tumors. Cancer. 1969; 23(5):1239-42. DOI: 10.1002/1097-0142(196905)23:5<1239::aid-cncr2820230535>3.0.co;2-f. View

14.

Evans A, HEYN R, NESBIT M, HARTMANN J . Evaluation of mitomycin C (NSC-26980) in the treatment of metastatic osteogenic sarcoma. Cancer Chemother Rep. 1969; 53(5):297-8. View

15.

Jaffe N, Traggis D, Enriquez C . Evaluation of a combination of mitomycin C (NSC-26980), phenylalanine mustard (NSC-14210), and vincristine (NSC-67574) in the treatment of osteogenic sarcoma. Cancer Chemother Rep. 1971; 55(2):189-91. View

16.

Jaffe N . Recent advances in the chemotherapy of metastatic osteogenic sarcoma. Cancer. 1972; 30(6):1627-31. DOI: 10.1002/1097-0142(197212)30:6<1627::aid-cncr2820300631>3.0.co;2-h. View

17.

Cores E, HOLLAND J, Wang J, Sinks L . Doxorubicin in disseminated osteosarcoma. JAMA. 1972; 221(10):1132-8. DOI: 10.1001/jama.221.10.1132. View

18.

Rosen G, Suwansirikul S, Kwon C, Tan C, Wu S, Beattie Jr E . High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma. Cancer. 1974; 33(4):1151-63. DOI: 10.1002/1097-0142(197404)33:4<1151::aid-cncr2820330439>3.0.co;2-8. View

19.

Jaffe N, Frei 3rd E, Traggis D, Bishop Y . Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma. N Engl J Med. 1974; 291(19):994-7. DOI: 10.1056/NEJM197411072911902. View

20.

Rosen G, Murphy M, Huvos A, Gutierrez M, Marcove R . Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma. Cancer. 1976; 37(1):1-11. DOI: 10.1002/1097-0142(197601)37:1<1::aid-cncr2820370102>3.0.co;2-3. View